JPWO2023060359A5 - - Google Patents
Info
- Publication number
- JPWO2023060359A5 JPWO2023060359A5 JP2024522502A JP2024522502A JPWO2023060359A5 JP WO2023060359 A5 JPWO2023060359 A5 JP WO2023060359A5 JP 2024522502 A JP2024522502 A JP 2024522502A JP 2024522502 A JP2024522502 A JP 2024522502A JP WO2023060359 A5 JPWO2023060359 A5 JP WO2023060359A5
- Authority
- JP
- Japan
- Prior art keywords
- self
- polypeptide complex
- mutation
- assembling
- igg4
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163256565P | 2021-10-16 | 2021-10-16 | |
| US63/256,565 | 2021-10-16 | ||
| PCT/CA2022/051517 WO2023060359A1 (en) | 2021-10-16 | 2022-10-14 | Modified multabody constructs, compositions, and methods targeting sars-cov-2 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024537398A JP2024537398A (ja) | 2024-10-10 |
| JPWO2023060359A5 true JPWO2023060359A5 (https=) | 2025-10-22 |
| JP2024537398A5 JP2024537398A5 (https=) | 2025-10-22 |
Family
ID=85987097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522502A Pending JP2024537398A (ja) | 2021-10-16 | 2022-10-14 | ＳＡＲＳ－ＣｏＶ－２を標的とする改変されたＭｕｌｔａｂｏｄｙ構築物、組成物、及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250011397A1 (https=) |
| EP (1) | EP4416189A4 (https=) |
| JP (1) | JP2024537398A (https=) |
| CA (1) | CA3235530A1 (https=) |
| WO (1) | WO2023060359A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69434520T3 (de) | 1993-07-30 | 2009-10-15 | Affymax, Inc., Palo Alto | Biotinylierung von proteinen |
| DE10113776B4 (de) | 2001-03-21 | 2012-08-09 | "Iba Gmbh" | Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins |
| EP1452601A1 (en) | 2003-02-28 | 2004-09-01 | Roche Diagnostics GmbH | Enhanced expression of fusion polypeptides with a biotinylation tag |
| JP2022543070A (ja) * | 2019-08-01 | 2022-10-07 | ザ ホスピタル フォー シック チルドレン | 多価及び多重特異性ナノ粒子プラットフォーム及び方法 |
| AU2022212978A1 (en) * | 2021-01-28 | 2023-08-31 | The Hospital For Sick Children | Multabody constructs, compositions, and methods |
-
2022
- 2022-10-14 WO PCT/CA2022/051517 patent/WO2023060359A1/en not_active Ceased
- 2022-10-14 JP JP2024522502A patent/JP2024537398A/ja active Pending
- 2022-10-14 US US18/701,187 patent/US20250011397A1/en active Pending
- 2022-10-14 CA CA3235530A patent/CA3235530A1/en active Pending
- 2022-10-14 EP EP22879729.6A patent/EP4416189A4/en active Pending